Online Learning Module Course Objectives
- Discuss what are the different types of stem cells and what their roles are.
- To discuss how we think stem cells work in different clinical situations.
- To review the advantages and disadvantages of stem cells from different sources
- Discuss how stem cells are prepared for clinical use.
- Review what exosomes are and how they differ from stem cells.
- Discuss we can tell if a stem cell or exosome product is legitimate.
- Autologous vs homologous biologics.
- Discuss the role of FDA in the regulation of regenerative products for clinical use
- To review whether the FDA allows the use of stem cells on patients and if so, under what conditions.
- Discuss the difference between 351 and 361 designations.
- Discuss what is Minimal manipulation of cells.
- Discuss what is classified as homologous use.
- To review the difference between allografts vs autografts: and what the practical difference is when using on patients.
- Discuss how fat and skin are elated and viewed by the FDA.
- Discuss how we make certain there is Compliance with the FDA Guidance
- Review how the Medical Boards view the use of these products.
- To review what an IND is and it is important
- Discuss what the relationship between PRP and Stem cells is and how they can be used together.
- To review how stem cells improve aesthetic care.
- To review how stem cells work in ablative or destructive skin treatments.
- Discuss the role of stem cells in the management of hair loss.
- Discuss how stem cells are used to improve fat transfer to volume loss areas.
- Discuss how stem cells are used to improve scar treatments.
- To review how we use stem cells in sexual medicine.
- Discuss when to use stem cells beyond skin and fat and under what conditions.
- Review the use of stem cells in autoimmune disorders.
- Evaluate the use of stem cells in neurocognitive disorders.
- Discuss the use of stem cells in arthritis.
- Review the use of stem cells in heart disease.
- Evaluate the use of stem cells for other systemic conditions.
Our Expert Faculty
The following presenter has disclosed the following relationships with commercial interest. All other presenters, planners or anyone in a position to control the content of this continuing medical education activity have indicated that neither they nor their spouse/legally recognized domestic partner has any financial relationships with commercial interests related to the content of this activity.
- AKAN Biosciences
Thom E. Lobe, M.D., FACS, ABAAFRM
Board Certified in General and Pediatric Surgery
Physicians: AKH Inc., Advancing Knowledge in Healthcare designates this enduring material for a maximum of 3.5 AMA PRA Category 1 Credit(s)™. Providers should claim only the credit commensurate with the extent of their participation in the activity.
Nurses: Credit being awarded: 3.5 ANCC contact hours
Physician Assistants: AKH Inc., Advancing Knowledge in Healthcare has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit
for activities planned in accordance with AAPA CME Criteria. This activity is designated for 3.5 AAPA Category 1 CME credits. Approval is valid until
6/30/2024. PAs should only claim credit commensurate with the extent of their participation.
Nurse Practitioners: This activity has been planned and implemented in accordance with the accreditation Standards of the American Association of Nurse Practitioners
(AANP) through the joint providership of AKH Inc., Advancing Knowledge in Healthcare and REVIVE™ Advanced Training Consultants. AKH Inc.,
Advancing Knowledge in Healthcare is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner
continuing education. Provider number: 030803. This activity is approved for 3.5 contact hours which includes 0 hours of pharmacology.
Commercial Support: This activity is supported by an educational grant from Athletic Integrative Medicine and Creska LLC.